Implementation of Multiple Evidence-Based Heart Failure Therapies.
Journal
Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
06
06
2022
accepted:
17
06
2022
pubmed:
27
6
2022
medline:
31
8
2022
entrez:
26
6
2022
Statut:
ppublish
Résumé
Despite the advancements in the management of heart failure, acute heart failure is one of the most common causes of mortality and morbidity. In light of the financial burden imposed by heart failure hospitalizations on the health care system, this area remains the focus of research, clinical advances, and policy changes aimed at improving the quality of care and outcomes. Despite practice guidelines, high-quality trial data, and consensus statements, barriers to therapy remain. The barriers related to physician, patient, economic, health care system, and logistical factors prevent widespread adoption of available therapeutics. In this review article, we outline guidelines directed therapies for heart failure, challenges associated with their implementation, and potential solutions to these challenges to help reduce mortality and improve clinical outcomes in this patient population.
Identifiants
pubmed: 35753401
pii: S0146-2806(22)00190-6
doi: 10.1016/j.cpcardiol.2022.101293
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101293Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.